Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): Price and Financial Metrics


Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL)

Today's Latest Price: $7.89 USD

0.09 (1.15%)

Updated Jan 28 11:15am

Add AVDL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 241 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AVDL Stock Summary

  • Of note is the ratio of Avadel Pharmaceuticals Plc's sales and general administrative expense to its total operating expenses; 99.86% of US stocks have a lower such ratio.
  • For AVDL, its debt to operating expenses ratio is greater than that reported by 93.28% of US equities we're observing.
  • Revenue growth over the past 12 months for Avadel Pharmaceuticals Plc comes in at -51.8%, a number that bests merely 4.64% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Avadel Pharmaceuticals Plc, a group of peers worth examining would be BDC, KNDI, LXRX, OI, and ORA.
  • Visit AVDL's SEC page to see the company's official filings. To visit the company's web site, go to www.avadel.com.

AVDL Stock Price Chart Interactive Chart >

Price chart for AVDL

AVDL Price/Volume Stats

Current price $7.89 52-week high $13.49
Prev. close $7.80 52-week low $4.00
Day low $7.80 Volume 172,086
Day high $8.10 Avg. volume 370,841
50-day MA $6.98 Dividend yield N/A
200-day MA $7.34 Market Cap 459.77M

Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) Company Bio


Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products based on its proprietary drug delivery technology for primary care and sterile injectable markets in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. The company was founded in 1990 and is based in Dublin, Ireland.


AVDL Latest News Stream


Event/Time News Detail
Loading, please wait...

AVDL Latest Social Stream


Loading social stream, please wait...

View Full AVDL Social Stream

Latest AVDL News From Around the Web

Below are the latest news stories about Avadel Pharmaceuticals Plc that investors may wish to consider to help them evaluate AVDL as an investment opportunity.

Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA

DUBLIN, Ireland, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) today announced the submission of its New Drug Application…

GlobeNewswire | December 16, 2020

Is AVDL A Good Stock To Buy Now?

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks aren’t doing […]

Yahoo | December 16, 2020

Avadel Pharmaceuticals Added to NASDAQ Biotechnology Index

DUBLIN, Ireland, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 21, 2020. The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. The NASDAQ Biotechnology Index is re-ranked annually. All securities in the index are listed on...

Yahoo | December 15, 2020

Avadel Pharmaceuticals Appoints Dr. Jennifer Gudeman as Vice President of Medical and Clinical Affairs

DUBLIN, Ireland, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, today announced the appointment of Dr. Jennifer Gudeman to the newly formed role of Vice President, Medical and Clinical Affairs, effective immediately. In this role her responsibilities will include overseeing all medical and clinical affairs activities, including the company’s lead program, once-nightly FT218. “We are pleased to further strengthen our team with the appointment of Dr. Gudeman. Her broad medical affairs experience will be especially valuable as we continue to establish and communicate the...

Yahoo | December 7, 2020

Avadel Pharmaceuticals to Present at Upcoming November 2020 Investor Conferences

DUBLIN, Ireland, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that members of the Avadel management team will present at both the Stifel Virtual Healthcare Conference and the Jefferies Virtual London Healthcare Conference that are being held in November 2020.   Event:Stifel 2020 Virtual Healthcare Conference  Date: Monday, November 16 Time: 9:20 a.m. ET Webcast: A webcast will be available at the “Investors” section of the Company’s website at www.avadel.com. A replay of the webcasts will be available on Avadel’s website for 90 days following the prese...

Yahoo | November 11, 2020

Read More 'AVDL' Stories Here

AVDL Price Returns

1-mo 25.44%
3-mo 56.55%
6-mo 0.77%
1-year 12.07%
3-year -32.10%
5-year -22.34%
YTD 18.11%
2020 -11.52%
2019 192.64%
2018 -68.54%
2017 -21.08%
2016 -14.91%

Continue Researching AVDL

Want to see what other sources are saying about Avadel Pharmaceuticals Plc's financials and stock price? Try the links below:

Avadel Pharmaceuticals Plc (AVDL) Stock Price | Nasdaq
Avadel Pharmaceuticals Plc (AVDL) Stock Quote, History and News - Yahoo Finance
Avadel Pharmaceuticals Plc (AVDL) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8821 seconds.